Utilization of spironolactone in patients with reduced or preserved ejection fraction heart failure

被引：0
|
作者：
Adimadhyam, Sruthi [1 ,2 ]
Cosgrove, Austin [1 ,2 ]
Her, Qoua L. [1 ,2 ]
Lyons, Jennifer [1 ,2 ]
Eworuke, Efe [3 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[3] US FDA, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
3717
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] Spironolactone in patients with heart failure and preserved ejection fraction
    Nunez, J.
    Nunez, E.
    Sanchis, J.
    [J]. REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 111 - 111
  • [2] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    [J]. REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [3] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Dalzell, Jonathan R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 179 - 179
  • [4] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Pitt, Bertram
    Pfeffer, Marc A.
    Assmann, Susan F.
    Boineau, Robin
    Anand, Inder S.
    Claggett, Brian
    Clausell, Nadine
    Desai, Akshay S.
    Diaz, Rafael
    Fleg, Jerome L.
    Gordeev, Ivan
    Harty, Brian
    Heitner, John F.
    Kenwood, Christopher T.
    Lewis, Eldrin F.
    O'Meara, Eileen
    Probstfield, Jeffrey L.
    Shaburishvili, Tamaz
    Shah, Sanjiv J.
    Solomon, Scott D.
    Sweitzer, Nancy K.
    Yang, Song
    McKinlay, Sonja M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15): : 1383 - 1392
  • [5] Reply to "Spironolactone in patients with heart failure and preserved ejection fraction"
    Sanchez-Sanchez, C.
    Martin-Casado, M.
    Formiga, F.
    Montero-Perez-Barquero, M.
    [J]. REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 112 - 112
  • [6] Spironolactone, fibrosis and heart failure with preserved ejection fraction
    Reddy, Yogesh N. V.
    Sundaram, Varun
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1569 - 1572
  • [7] Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
    Solomon, Scott D.
    Claggett, Brian
    Lewis, Eldrin F.
    Desai, Akshay
    Anand, Inder
    Sweitzer, Nancy K.
    O'Meara, Eileen
    Shah, Sanjiv J.
    McKinlay, Sonja
    Fleg, Jerome L.
    Sopko, George
    Pitt, Bertram
    Pfeffer, Marc A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (05) : 455 - 462
  • [8] Prognostic impact of spironolactone in patients with heart failure with preserved ejection fraction
    Antunes, H. Hugo
    Gil, J.
    Goncalves, M. L.
    Abreu, L.
    Marmelo, B.
    Pires, I.
    Moreira, D.
    Almeida, I.
    Correia, M.
    Cabral, C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 154 - 155
  • [9] End of Life Resource Utilization in Heart Failure Patients with Preserved and Reduced Ejection Fraction
    Dunlay, Shannon M.
    Redfield, Margaret M.
    Weston, Susan A.
    Jiang, Ruoxiang
    Roger, Veronique L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S11 - S11
  • [10] Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Dunlay, Shannon M.
    Roger, Veronique L.
    Weston, Susan A.
    Jiang, Ruoxiang
    Redfield, Margaret M.
    [J]. CIRCULATION-HEART FAILURE, 2012, 5 (06) : 720 - 726
12345